David Ramírez

2.7k total citations · 1 hit paper
76 papers, 1.9k citations indexed

About

David Ramírez is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, David Ramírez has authored 76 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 18 papers in Computational Theory and Mathematics and 9 papers in Organic Chemistry. Recurrent topics in David Ramírez's work include Computational Drug Discovery Methods (18 papers), Ion channel regulation and function (18 papers) and Cholinesterase and Neurodegenerative Diseases (7 papers). David Ramírez is often cited by papers focused on Computational Drug Discovery Methods (18 papers), Ion channel regulation and function (18 papers) and Cholinesterase and Neurodegenerative Diseases (7 papers). David Ramírez collaborates with scholars based in Chile, Colombia and Spain. David Ramírez's co-authors include Julio Caballero, Ana Martı́nez, Wendy González, Carmen Gil, Vanesa Nozal, Nuria E. Campillo, Inés Maestro, Tiziana Ginex, Miguel Ángel Cuesta-Geijo and Covadonga Alonso and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

David Ramírez

69 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data?

2018 394 citations David Ramírez, Julio Caballero Molecules profile →

Peers

Countries citing papers authored by David Ramírez

Since Specialization

Citations

This map shows the geographic impact of David Ramírez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ramírez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ramírez more than expected).

Fields of papers citing papers by David Ramírez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ramírez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ramírez. The network helps show where David Ramírez may publish in the future.

Co-authorship network of co-authors of David Ramírez

This figure shows the co-authorship network connecting the top 25 collaborators of David Ramírez. A scholar is included among the top collaborators of David Ramírez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ramírez. David Ramírez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers 2025 ·Neurobiology of Disease ·Eva P. Cuevas, Enrique López Madruga, (unknown), David Ramírez, Carmen Gil, Siranjeevi Nagaraj, Ángeles Martín‐Requero, Ana Martı́nez	2
2	The ROCK Inhibitor Fasudil and Sertraline Share Morphological and Molecular Effects in the Hippocampus of Chronically Stressed Rats: Exploring Common Antidepressant Pathways by Network Pharmacology 2025 ·ACS Pharmacology & Translational Science ·(unknown), (unknown), (unknown), (unknown), David Ramírez, Jenny L. Fiedler	1
3	Identification of Antioxidant Methyl Derivatives of Ortho-Carbonyl Hydroquinones That Reduce Caco-2 Cell Energetic Metabolism and Alpha-Glucosidase Activity 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), David Ramírez, Félix A. Urra, Maximiliano Martínez‐Cifuentes, Ramiro Araya‐Maturana	2
4	AlzyFinder: A Machine-Learning-Driven Platform for Ligand-Based Virtual Screening and Network Pharmacology 2024 ·Journal of Chemical Information and Modeling ·(unknown), (unknown), (unknown), (unknown), Fernanda I. Saldívar‐González, Paula Santana, Janneth González, (unknown), (unknown), David Ramírez	0
5	Impedimetric Sensor for SARS-CoV-2 Spike Protein Detection: Performance Assessment with an ACE2 Peptide-Mimic/Graphite Interface 2024 ·Biosensors ·(unknown), Beatriz Sánchez Herrera, (unknown), Juan Luis Palma, (unknown), Claudio Ãlvarez, (unknown), (unknown), David Ramírez, Paula Santana, Manuel Ahumada	2
6	Constitutive sodium permeability in a Caenorhabditis elegans two-pore domain potassium channel 2024 ·Proceedings of the National Academy of Sciences ·Olga Andrini, (unknown), (unknown), Denise S. Walker, (unknown), David Ramírez, Marie Gendrel, (unknown), Sonia El Mouridi, (unknown), Wendy González, William R Schafer, Maëlle Jospin, Thomas Boulin	0
7	The pharmacoepigenetic paradigm in cancer treatment 2024 ·Frontiers in Pharmacology ·(unknown), (unknown), David Ramírez, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	13
8	Integrated multi-omics analysis reveals the molecular interplay between circadian clocks and cancer pathogenesis 2023 ·Scientific Reports ·(unknown), (unknown), (unknown), Lavanya Prathap, (unknown), David Ramírez, Jennyfer M. García-Cárdenas, Isaac Armendáriz‐Castillo, Santiago Guerrero, Clara Paz, Andrés López‐Cortés	29
9	Iridoid esters from Valeriana pavonii Poepp. & Endl. as GABAA modulators: Structural insights in their binding mode and structure-activity relationship 2023 ·Journal of Pharmacy & Pharmacognosy Research ·(unknown), (unknown), (unknown), Paula Santana, Isabel L. Bazzocchi, Ignacio A. Jiménez, Mariel Marder, (unknown), Mario Guerrero, David Ramírez	2
10	Common Structural Pattern for Flecainide Binding in Atrial-Selective Kv1.5 and Nav1.5 Channels: A Computational Approach 2022 ·Pharmaceutics ·(unknown), (unknown), David Ramírez, Leandro Zúñiga, Niels Decher, Ursula Ravens, Vladimir Yarov‐Yarovoy, Wendy González	3
11	TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy 2022 ·Journal of Medicinal Chemistry ·Vanesa Nozal, Loreto Martínez‐González, (unknown), (unknown), Paula Santana, A. Chaikuad, Eva P. Cuevas, Stefan Knapp, Daniel Lietha, David Ramírez, Sabrina Petralla, Barbara Monti, Carmen Gil, Ángeles Martín‐Requero, Valle Palomo, Eva de Lago, Ana Martı́nez	28
12	Identification of a critical binding site for local anaesthetics in the side pockets of K_v1 channels 2021 ·British Journal of Pharmacology ·Aytuğ K. Kiper, (unknown), (unknown), (unknown), David Ramírez, Alicia de la Cruz, (unknown), (unknown), (unknown), (unknown), Susanne Rinné, Teresa González, Carmen Valenzuela, Wendy González, Niels Decher	3
13	5-(Indol-2-yl)pyrazolo[3,4-b]pyridines as a New Family of TASK-3 Channel Blockers: A Pharmacophore-Based Regioselective Synthesis 2021 ·Molecules ·David Ramírez, (unknown), Braulio Insuasty, Susanne Rinné, Aytuğ K. Kiper, (unknown), Thomas Müller, Niels Decher, Jairo Quiroga, Pedro De‐la‐Torre, Wendy González	5
14	Discovery of Novel TASK-3 Channel Blockers Using a Pharmacophore-Based Virtual Screening 2019 ·International Journal of Molecular Sciences ·David Ramírez, (unknown), (unknown), (unknown), Leandro Zúñiga, Aytuğ K. Kiper, Susanne Rinné, Miguel Reyes‐Parada, Niels Decher, Wendy González, Julio Caballero	17
15	Theoretical and Experimental Approaches Aimed at Drug Design Targeting Neurodegenerative Diseases 2019 ·Processes ·(unknown), (unknown), (unknown), (unknown), Oscar Forero‐Doria, Wendy González, (unknown), Miguel Reyes‐Parada, Ana Martı́nez, David Ramírez	7
16	An important role for periplasmic storage in Pseudomonas aeruginosa copper homeostasis revealed by a combined experimental and computational modeling study 2018 ·Molecular Microbiology ·Jignesh H. Parmar, Julia Quintana, David Ramírez, Reinhard Laubenbacher, José Argüello, Pedro Mendes	13
17	Origin and evolution of transporter substrate specificity within the NPF family 2017 ·eLife ·Morten Egevang Jørgensen, Deyang Xu, Christoph Crocoll, Heidi A. Ernst, David Ramírez, Mohammed Saddik Motawia, Carl Erik Olsen, Osman Mirza, Hussam Hassan Nour‐Eldin, Barbara Ann Halkier	90
18	Exploring and understanding the functional role, and biochemical and structural characteristics of an acidic phospholipase A2, AplTx-I, purified from Agkistrodon piscivorus leucostoma snake venom 2017 ·Toxicon ·L.M. Resende, José R. Almeida, (unknown), (unknown), (unknown), David Ramírez, Wendy González, Andreimar M. Soares, Leonardo A. Calderón, Sérgio Marangoni, Saulo L. da Silva	10
19	Kv1.5 blockers preferentially inhibit TASK-1 channels: TASK-1 as a target against atrial fibrillation and obstructive sleep apnea? 2014 ·Pflügers Archiv - European Journal of Physiology ·Aytuğ K. Kiper, Susanne Rinné, (unknown), David Ramírez, Guiscard Seebohm, Michael F. Netter, Wendy González, Niels Decher	47
20	Análisis retrospectivo de historias clínicas de pacientes intervenidos por cirugía maxilofacial en el Hospital General de Medellín 2007 ·Gustavo Ortiz, Juan Carlos Arango, (unknown), David Ramírez, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact